Atribución-NoComercial 3.0 España © Ferrata Storti Foundation. Santiago Montes Moreno...[ et al.], 2014, Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. "Obtained from the Haematologica Journal website http://www.haematologica.org"Except where otherwise noted, this item's license is described as Atribución-NoComercial 3.0 España © Ferrata Storti Foundation. Santiago Montes Moreno...[ et al.], 2014, Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. "Obtained from the Haematologica Journal website http://www.haematologica.org"